JONICA PAGNUCCO: Open Payments
NPI 1245437037 · WATERBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,254 in 115 payments from 12 companies in 2025. Trend: 2023 $6,826 · 2024 $5,339 · 2025 $6,254
Speaker / faculty: $4,104Food & beverage: $2,141Travel & lodging: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $5,009 |
| Novartis Pharmaceuticals Corporation | 20 | $366 |
| PFIZER INC. | 20 | $322 |
| Genentech USA, Inc. | 10 | $158 |
| ARGENX US, INC. | 3 | $87 |
| Amgen Inc. | 4 | $83 |
| Celgene Corporation | 4 | $81 |
| TG Therapeutics, Inc. | 2 | $58 |
| Neurelis, Inc. | 1 | $37 |
| UCB, Inc. | 1 | $20 |
Products named: QULIPTA, UBRELVY, KESIMPTA, NURTEC ODT, Ocrevus Zunovo, BOTOX, VYVGART HYTRULO, UPLIZNA.
Industry payments across CT — which companies pay providers there.
